{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:40:07Z","timestamp":1778902807052,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1756-0500-6-362","type":"journal-article","created":{"date-parts":[[2013,9,9]],"date-time":"2013-09-09T08:14:03Z","timestamp":1378714443000},"source":"Crossref","is-referenced-by-count":19,"title":["Tyrosinemia type 1: a rare and forgotten cause of reversible hypertrophic cardiomyopathy in infancy"],"prefix":"10.1186","volume":"6","author":[{"given":"Sarar","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A","family":"Kambal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasir A","family":"Al Jurayyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman","family":"Al-Nemri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Babiker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Hasanato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah S","family":"Al-Jarallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,9]]},"reference":[{"key":"2382_CR1","first-page":"1777","volume-title":"Hypertyrosinemia : the metabolic and molecular bases of inherited disease","author":"GA Mitchell","year":"2001","unstructured":"Mitchell GA, Grompe M, Lambert M, Tanguay RM: Hypertyrosinemia : the metabolic and molecular bases of inherited disease. Edited by: Scriver CR, Beaudet A, Sly WS, Valle D. 2001, New York: McGraw Hill, 1777-1806. 5","edition":"5"},{"key":"2382_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ab.2005.01.014","volume":"339","author":"MS Rashed","year":"2005","unstructured":"Rashed MS, Al-Ahaidib LY, Al-Dirbashi OY: Tandem mass spectrometric assay of succinylacetone in urine for diagnosis of hepatorenaltyrosinemia. Anal Biochem. 2005, 339: 310-317. 10.1016\/j.ab.2005.01.014.","journal-title":"Anal Biochem"},{"issue":"1","key":"2382_CR3","first-page":"64","volume":"11","author":"M Rashad","year":"2011","unstructured":"Rashad M, Nassar C: Tyrosinemia type 1: a case report. Sudan J Pediatr. 2011, 11 (1): 64-67.","journal-title":"Sudan J Pediatr"},{"issue":"1","key":"2382_CR4","first-page":"31","volume":"25","author":"J Wilkinson","year":"2008","unstructured":"Wilkinson J, Sleeper L, Alvarez J, Bublik N, Lipshultz S: The pediatric cardiomyopathy registry: 1995\u20132007. ProgPediatrCardiol. 2008, 25 (1): 31-36.","journal-title":"ProgPediatrCardiol"},{"issue":"17","key":"2382_CR5","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa021737","volume":"348","author":"AW Nugent","year":"2003","unstructured":"Nugent AW, Daubeney PEF, Chondros P, Carlin JB, Cheung M, Wilkinson LC, Davis AM, Kahler SG, Chow CW, Wilkinson JL, Weintraub RG: National Australian childhood cardiomyopathy study.: the epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003, 348 (17): 1639-1646. 10.1056\/NEJMoa021737.","journal-title":"N Engl J Med"},{"key":"2382_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s10545-006-0203-5","volume":"29","author":"N Arora","year":"2006","unstructured":"Arora N, Staper O, Wright J, Kelly D, Mckiernan P: Cardiomyopath in tyrosinemia type 1 is common but usually benign. J Inherit Metab Dis. 2006, 29: 54-57. 10.1007\/s10545-006-0203-5.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"2382_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/BF01811439","volume":"10","author":"B Lindblad","year":"1987","unstructured":"Lindblad B, Fallstrom SP, Hoyer S, Nordborg C, Solymar L, Velander H: Cardiomyopathy in fumarylscetoacetase deficiency (hereditary tyrosinemia): a new feature of the disease. J Inherit Metab Dis. 1987, 10 (2): 319-322.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2382_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10545-005-5085-4","volume":"28","author":"N Andre\u2019","year":"2005","unstructured":"Andre\u2019 N, Roquelaure B, Jubin V, Ovaert C: Successful treatment of severe cardiomyopathy with NTBC in a child with tyrosinemia type 1. J Inherit Metab Dis. 2005, 28 (1): 103-106. 10.1007\/s10545-005-5085-4.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"2382_CR9","first-page":"249","volume":"158","author":"N Mohan","year":"1999","unstructured":"Mohan N, McKiernan P, Preece MA, Green A, Buckels J, Mayer AD, Kelly DA: Indications and outcome of liver transpalntaion in tyrosinemia type 1. Eur J Pediatr. 1999, 158 (2): 249-254.","journal-title":"Eur J Pediatr"},{"key":"2382_CR10","first-page":"302","volume":"47","author":"M De Braekeleer","year":"1990","unstructured":"De Braekeleer M, Larochelle J: Genetic epidemiology of hereditary tyrosinemia in Quebec and in Saguenary-Lac-St-Jean. Am J Hum Genet. 1990, 47: 302-307.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"2382_CR11","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ymgme.2011.06.019","volume":"104","author":"F Imtiaz","year":"2011","unstructured":"Imtiaz F, Rashed M, Al Mubarak B, Allam R, El-Karaksy H, Al-Hassnan Z, Al-Owain M, Al-Zaidan H, Rahbeeni Z, Qari A, Meyer BF, Al-Sayed M: Identification of mutation causing hereditary TyrosinemiaType 1 in patients of Middle Eastern origin. Mol Genet Metab. 2011, 104 (4): 688-690. 10.1016\/j.ymgme.2011.06.019.","journal-title":"Mol Genet Metab"},{"key":"2382_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/(SICI)1098-1004(1998)12:1<19::AID-HUMU3>3.0.CO;2-3","volume":"12","author":"AJ Bergman","year":"1998","unstructured":"Bergman AJ, van den Berg IE, Brink W, Poll-The BT, Ploos van Amstel JK, Berger R: Spectrum of mutations in the fumarylacetoacetatehydrolase gene of tyrosinemia type 1 patients in Northwestern Europe and Mediterranean countries. Hum Mutat. 1998, 12: 19-26. 10.1002\/(SICI)1098-1004(1998)12:1<19::AID-HUMU3>3.0.CO;2-3.","journal-title":"Hum Mutat"},{"issue":"3","key":"2382_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1542\/peds.103.3.675","volume":"103","author":"JM Croffie","year":"1999","unstructured":"Croffie JM, Gupta SK, Chong SK, Fitzgerald JF: Tyrosinemia type 1 should be suspected in infants with severe coagulopathy even in the absence of other signs of liver failure. Pediatrics. 1999, 103 (3): 675-678. 10.1542\/peds.103.3.675.","journal-title":"Pediatrics"},{"key":"2382_CR14","doi-asserted-by":"publisher","first-page":"bcr0720103150","DOI":"10.1136\/bcr.07.2010.3150","volume":"2010","author":"H Georgouli","year":"2010","unstructured":"Georgouli H, Schulpis KH, Michelakaki H, Kaltsa M, Sdogou T, Kossiva L: Persistent coagulopathy during Escherichia coli sepsis in a previously healthy infant revealed undiagnosed tyrosinaemia type 1. BMJ Case Rep. 2010, 2010: bcr0720103150-10.1136\/bcr.07.2010.3150.doi:10.1136\/bcr.07.2010.3150.,","journal-title":"BMJ Case Rep"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-6-362.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T17:42:23Z","timestamp":1548092543000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-6-362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,9]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2382"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-6-362","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,9]]},"article-number":"362"}}